Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...
Antibody-drug conjugates are receiving unrivaled attention across the biopharma sector. Fueled by Enhertu’s tumor-agnostic accelerated approval, practice changing combination results from Seagen and ...
ESP32 projects and tutorials you can visit this webstie for more information about these tutorials with step by step guide https://microcontrollerslab.com/ Follow ...
It can be used for chip evaluation, program pre-research and personal DIY, and can be applied to product forms such as game consoles, smart commercial displays, HMI, and smart central control. D1s is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback